Iridex Announces Appointment Of Ann Rhoads To Its Board Of Directors
Iridex Corporation announced the appointment of Ann Rhoads to the company's board of directors, Audit Committee, and Compensation Committee, effective immediately.
"We are delighted to add Ann to our board of directors. Her significant experience working with growth companies from a financial and strategic perspective, particularly in the health care sector, makes her an ideal addition to our leadership team," William M. Moore, President and Chief Executive Officer, said in a company news release. "Moreover, I am confident that her expertise in creating and implementing corporate strategies will be instrumental in enabling us to continue gaining traction and expanding our presence in the global ophthalmology market. We look forward to her insight."
Rhoads served as Executive Vice President and Chief Financial Officer of Zogenix, a publicly-traded pharmaceutical company, where she played a key role in the company's strategic positioning, business development, and financial oversight. Prior to her tenure at Zogenix, Rhoads served as Chief Financial Officer and Senior Vice President of Premier, a health care service company, where her responsibilities included all areas of financial management, strategic planning, business development, information technology, ethics, and compliance. She also served as Vice President at The Sprout Group, a venture capital firm focused on emerging growth companies.
"Iridex is advancing differentiated and clinically significant technology in the growing ophthalmology market," Ms. Rhoads said in the news release. "I am honored to join their board of directors and excited to contribute to a company positioned to deliver value in our evolving health care system."
Ms. Rhoads is currently a member of the board of directors and chairs the audit committee of Globus Medical, and Evoke Pharma. Previously, she served on the board and chaired the audit committee of Novellus Systems prior to its acquisition. Rhoads holds an M.B.A. from the Harvard Graduate School of Business Administration and a B.S. in Finance from the University of Arkansas.
You must be logged in to leave a comment.